Quick Search

 

 


 

 

Result Summary for ALKF1001

Result Summary
Protocol ID: ALKF1001
Clinical Study ID: ALKF1001
Official Title: Report of a Biocomparability Study of Alkeran (melphalan) in Patients with Multiple Myeloma, Ovarian Cancer, Breast Cancer or other solid tumors for which Alkeran has activity.
Phase: Phase 1
Study Indications or Diseases:
  • Solid Tumours
Generic Name: melphalan
Trade/Product Name: alkeran;alkeran
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.